Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).

@article{Hofman2015ModifyingTP,
  title={Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).},
  author={Michael S Hofman and Michael Michael and Raghava Kashyap and Rodney J Hicks},
  journal={Journal of nuclear medicine : official publication, Society of Nuclear Medicine},
  year={2015},
  volume={56 6},
  pages={968-9}
}